ATE360423T1 - Verwendung von chymase hemmern gegen vaskuläre lipidablagerung - Google Patents

Verwendung von chymase hemmern gegen vaskuläre lipidablagerung

Info

Publication number
ATE360423T1
ATE360423T1 AT00971729T AT00971729T ATE360423T1 AT E360423 T1 ATE360423 T1 AT E360423T1 AT 00971729 T AT00971729 T AT 00971729T AT 00971729 T AT00971729 T AT 00971729T AT E360423 T1 ATE360423 T1 AT E360423T1
Authority
AT
Austria
Prior art keywords
inhibitors against
against vascular
chymase inhibitors
lipid deposit
vascular lipid
Prior art date
Application number
AT00971729T
Other languages
English (en)
Inventor
Harukazu Fukami
Hidenori Urata
Original Assignee
Daiichi Asubio Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daiichi Asubio Pharma Co Ltd filed Critical Daiichi Asubio Pharma Co Ltd
Application granted granted Critical
Publication of ATE360423T1 publication Critical patent/ATE360423T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT00971729T 1999-11-01 2000-11-01 Verwendung von chymase hemmern gegen vaskuläre lipidablagerung ATE360423T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP31125799 1999-11-01

Publications (1)

Publication Number Publication Date
ATE360423T1 true ATE360423T1 (de) 2007-05-15

Family

ID=18014979

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00971729T ATE360423T1 (de) 1999-11-01 2000-11-01 Verwendung von chymase hemmern gegen vaskuläre lipidablagerung

Country Status (11)

Country Link
US (1) US6921766B1 (de)
EP (1) EP1142586B1 (de)
KR (1) KR20010100004A (de)
CN (1) CN1335778A (de)
AT (1) ATE360423T1 (de)
AU (1) AU784467B2 (de)
CA (1) CA2358314A1 (de)
DE (1) DE60034545T2 (de)
ES (1) ES2281358T3 (de)
HU (1) HUP0104952A3 (de)
WO (1) WO2001032214A1 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1245979C (zh) 2000-02-22 2006-03-22 第一阿斯比奥制药株式会社 含有胃促胰酶抑制剂作为有效成分的预防和治疗皮炎的药物
CN1366461A (zh) 2000-02-22 2002-08-28 三得利株式会社 含有胃促胰酶抑制剂作为有效成分的预防或治疗纤维变性的药物
EP1174151B1 (de) 2000-02-22 2007-01-24 Daiichi Asubio Pharma Co., Ltd. Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
WO2003007964A1 (en) * 2001-07-18 2003-01-30 Nippon Kayaku Kabushiki Kaisha Remedial or preventive agent for cardiopathy or aneurysm containing chymase inhibitory compound
EP1601380A1 (de) * 2003-02-13 2005-12-07 Licentia OY Verwendung eines mastzellen-aktivierenden oder degranulationshemmenden mittels bei der herstellung eines medikaments zur behandlung von zerebralischämie
CN101160290B (zh) 2004-12-02 2011-01-19 第一三共株式会社 7-元环化合物、其制备方法和药物用途
AU2007268507B2 (en) 2006-05-31 2012-01-19 Daiichi Sankyo Company, Limited Seven-membered ring compound, production method thereof and pharmaceutical use thereof
PT2239257E (pt) * 2008-01-30 2012-09-12 Shin Poong Pharmaceutical Co Ltd Novo derivado de quinazolina-2,4-diona e composições médicas para a profilaxia e tratamento da doença dos nervos cranianos contendo o dito derivado
JP6364362B2 (ja) * 2015-02-17 2018-07-25 学校法人福岡大学 ヒトキマーゼ阻害剤および機能性食品、並びにヒトキマーゼの活性を阻害する方法
AU2017416068A1 (en) 2017-05-24 2019-10-31 The Provost, Fellows, Foundation Scholars, And Other Members Of Board, Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin Novel compounds and uses

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5199279A (en) 1991-08-13 1993-04-06 Reynolds Martin M Drum contact freezer system and method
JP2982454B2 (ja) 1991-12-20 1999-11-22 王子製紙株式会社 感熱記録体
EP0644892A1 (de) 1992-06-12 1995-03-29 Pfizer Inc. Inhibitoren für Angiotensin I-Chymasen inklusive der menschlichen Herzchymase
AU3086095A (en) 1994-07-29 1996-03-04 Suntory Limited Imidazolidine derivative and use thereof
EP0826671B1 (de) 1995-04-27 2004-12-29 Mitsubishi Pharma Corporation Heterocyclische amidverbindungen und deren medizinische verwendung
US5596111A (en) 1995-06-05 1997-01-21 North Dakota State University Method for preparation of carboxylic acids
DE69622148T2 (de) 1995-09-28 2002-10-31 Suntory Limited, Osaka Chinazozin derivate und deren verwendung
CA2255858C (en) 1996-05-24 2007-09-11 Neurosearch A/S Phenyl derivatives containing an acidic group, their preparation and their use as chloride channel blockers
AUPO062696A0 (en) * 1996-06-24 1996-07-18 Fujisawa Pharmaceutical Co., Ltd. Novel compounds
EP0940400A4 (de) * 1996-10-25 2002-10-02 Mitsubishi Pharma Corp Heterocyklische amidverbindungen und ihre medizinische anwendung
EP1055683A4 (de) 1998-02-17 2007-07-25 Nippon Kayaku Kk Neuartiges acetamid-derivat und verwendung desselben
ES2259476T3 (es) * 1998-08-21 2006-10-01 Daiichi Asubio Pharma Co., Ltd. Derivados de quinazolina y sus aplicaciones farmaceuticas.
AU1414000A (en) * 1998-12-01 2000-06-19 Meiji Seika Kaisha Ltd. Sf2809-i, ii, iii, iv, v and vi substances exhibiting chymase-inhibiting activities

Also Published As

Publication number Publication date
HUP0104952A2 (en) 2002-06-29
AU1053601A (en) 2001-05-14
DE60034545T2 (de) 2007-10-25
CN1335778A (zh) 2002-02-13
KR20010100004A (ko) 2001-11-09
EP1142586A4 (de) 2003-03-19
EP1142586B1 (de) 2007-04-25
DE60034545D1 (de) 2007-06-06
ES2281358T3 (es) 2007-10-01
HUP0104952A3 (en) 2006-02-28
EP1142586A1 (de) 2001-10-10
US6921766B1 (en) 2005-07-26
CA2358314A1 (en) 2001-05-10
WO2001032214A1 (en) 2001-05-10
AU784467B2 (en) 2006-04-06

Similar Documents

Publication Publication Date Title
NO20071042L (no) 5-substituerte 2-fenylaminobenzamider som MEK-inhibitorer
ATE475652T1 (de) Chinazolinderivate
DE69519921D1 (de) Imidazolidin-derivate und ihre verwendung
EP1258252A4 (de) Inhibitoren der integrinexpression
NO950297D0 (no) Prolinamidderivater
EP0795548A4 (de) Chinazozin derivate und deren verwendung
TR200201505T2 (tr) Terapötik maddeler olarak pirazolopirimidinler
DE69221290D1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
ATE305777T1 (de) Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation
NO20055565L (no) Anvendelse av derivater av 2,4-dihydro-[1,2,4]triazol-3-thion som inhibitorer av enzymet myeloperoksidase (MPO)
EP0815859A4 (de) Intimale verdickungsinhibitoren
ATE360423T1 (de) Verwendung von chymase hemmern gegen vaskuläre lipidablagerung
WO2003048122A3 (en) Inhibitors of cytosolic phospholipase a2
NO20032261D0 (no) Medisinske preparater
AR002761A1 (es) Un compuesto derivado del triazol, su uso, una composicion farmaceutica que lo contiene, un metodo de tratamiento o prevencion de una infeccion fungica enun paciente humano mediante dicho compuesto o composicion, y procedimiento y compuestos intermedios para prepararlo.
DK1157998T3 (da) Heterocykliske forbindelser, mellemprodukter derfor og elastaseinhibitorer
SE9704770D0 (sv) New use
NO20070421L (no) Radiosensitiviserende middel
PT1245564E (pt) Derivados de benzamidina.
BR0307266A (pt) Compostos que inibem a atividade do fator xa
DE60008584D1 (de) Benzamidin-derivate
ATE535242T1 (de) Medizinische zusammensetzung zur prävention des übergangs zu einer operativen behandlung bei prostatahypertrophie
EP1201664A4 (de) Bemzimidazolverbindungen und medikamente die diese enthalten
ATE380028T1 (de) Mittel zur anregung des appetits und mittel zur behandlung von anorexie
WO2004056306A3 (de) Verwendung von l-dopa, seiner derivate und diese verbindungen enthaltender arzneimittel zur prophylaxe psychotischer erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties